• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Nexus Receives FDA Approval of Erythromycin Lactobionate for Injection, USP

    BUSINESSWIRE

    Nexus Pharms` Generic Erythromycin Lactobionate Receives Approval in the U.S.

    FDA

    Exela Pharma`s Generic Erythromycin Lactobionate Receives Approval In US

    FDA

    Prescription med: registration of new generics & biosimilars

    TGA GOV

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.